NEW YORK, July 25 – GeneMachines has sold two OmniGrid microarrayers to the Genome Institute of Singapore, the company said Wednesday. 

The Genome Institute will use the microarrayers in its work on zebrafish and mouse model systems, as well as cancer genomics and other research that comprises part of Singapore’s promised $4 billion investment in genomics and biotechnology. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.